the development of generalized whole-body itching immediately following the first dose of AKURIT-4 (a fixed-dose combination for Tuberculosis) is a significant clinical event. This strongly points toward an acute drug-induced allergic reaction or hypersensitivity to one of the active anti-tubercular components (such as Rifampicin or Isoniazid), rather than a benign cutaneous response.
Next Steps
The history of being Hepatitis B positive, even if classified as inactive with previously normal
Liver Function Tests (LFTs), introduces a higher level of clinical risk. Anti-tubercular medications in AKURIT-4 carry a well-documented risk of drug-induced liver injury (DILI), which can potentially cause bile salt accumulation manifesting as severe pruritus (itching) or even trigger a reactivation of the underlying viral hepatitis.
Health Tips
To clinically review your father's baseline pre-therapy
liver function data, accurately evaluate the progression of his skin itching, and coordinate a safe anti-tubercular modification plan, please book a full consultation session via my Practo profile."